Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
This study has been completed.
Sponsor:
University Hospital, Akershus
Collaborator:
Solvay Pharmaceuticals
Information provided by (Responsible Party):
Christofer Lundqvist, Akershus University College
ClinicalTrials.gov Identifier:
NCT00272688
First received: January 6, 2006
Last updated: October 31, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2009 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |